Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical and Quantitative Research

Global ETF Synopsis: Highlighting Technical Trends Across the ETF Universe

S&P Macro Peak in Sight on Projection, Support and Rotation Synergy

S&P 500: A Pause in the Uptrend - More Consolidation Expected.

S&P 500 Bullish but Extended; Downgrading Financials

U.S. Strategy: Sentiment Improving, Upgrading Manufacturing

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical Analysis

<p>Investors continue to prefer the stability of the U.S. relative to emerging markets. The recent declines recorded in emerging markets and their currencies suggest global risk aversion. U.S. equity markets are, by contrast, not showing any significant signs of coming unhinged as a result of this rout in emerging markets.  In this report we examine the factors likely to impact the U.S. equity markets, and explore actionable opportunities within the Technology, Consumer Discretionary, and Health Care Sectors.</p>

Investors continue to prefer the stability of the U.S. relative to emerging markets. The recent declines recorded in emerging markets and their currencies suggest global risk aversion. U.S. equity markets are, by contrast, not showing any significant signs of coming unhinged as a result of this rout in emerging markets.  In this report we examine the factors likely to impact the U.S. equity markets, and explore actionable opportunities within the Technology, Consumer Discretionary, and Health Care Sectors.

Pacific Biosciences Of California (PACB US)

U.S. Equity Strategy: Cyclicals Remain Leadership - Staples & Utilities Are Strengthening

S&P 500 INDEX

U.S. Equity Strategy: Cyclicals Remain Leadership - Staples & Utilities Are Strengthening